Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 2/20 | 0.49 |
| ▸ | GNAO1 | P09471 | 9/20 | 0.37 |
| ▸ | GNAI3 | P08754 | 8/20 | 0.37 |
| ▸ | GNAI1 | P63096 | 8/20 | 0.37 |
| ▸ | CXCR4 | P61073 | 1/20 | 0.35 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.34 |
| ▸ | EBP | Q15125 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | SOD3 | P08294 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27877149 | 0.98 | ALOX5 (0.51) | ALOX5GNAO1GNAI3GNAI1CXCR4 | |
| Methylamine SCHEMBL27943477 | 0.94 | ALOX5 (0.49) | ALOX5GNAO1GNAI3GNAI1CXCR4 | |
| SCHEMBL4551459 | 0.94 | ALOX5 (0.47) | ALOX5GNAO1GNAI3GNAI1MEN1 | |
| SCHEMBL1741781 | 0.93 | — | — | |
| Methylamine SCHEMBL27943479 | 0.89 | ALOX5 (0.40) | ALOX5GNAO1GNAI3GNAI1CXCR4 | |
| SCHEMBL27293688 | 0.87 | ALOX5 (0.41) | ALOX5GNAO1GNAI3GNAI1MEN1 | |
| SCHEMBL7022863 | 0.84 | — | — | |
| SCHEMBL9449545 | 0.78 | CXCR4 (0.35) | ALOX5CXCR4 | |
| SCHEMBL2009978 | 0.78 | CXCR4 (0.35) | ALOX5CXCR4SIGMAR1 | |
| SCHEMBL3313745 | 0.78 | ALOX5 (0.49) | ALOX5GNAO1GNAI3GNAI1CXCR4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117964605-A | Arylpyrazole pyridine derivative and preparation method and application thereof | 北京工业大学 | 2024-05-03 | — | — | CN | claimed |
| EP-1731509-B1 | PROCESS FOR PRODUCING NITROGENOUS 5-MEMBERED CYCLIC COMPOUND | JAPAN SCIENCE & TECH AGENCY (JP) | 2011-10-19 | — | — | EP | claimed |
| US-7705161-B2 | Process for producing nitrogenous 5-membered cyclic compound | JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) | 2010-04-27 | — | — | US | claimed |
| US-20070191614-A1 | Process for producing nitrogenous 5-membered cyclic compound | JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) | 2007-08-16 | — | — | US | claimed |
| EP-1731509-A1 | PROCESS FOR PRODUCING NITROGENOUS 5-MEMBERED CYCLIC COMPOUND | Japan Science and Technology Agency (JP) | 2006-12-13 | — | — | EP | claimed |
| CN-114539157-B | Method for preparing 4-iodo-N-aryl pyrazole compound by iodine-promoted oxidation method | 曲靖师范学院 | 2023-12-22 | — | — | CN | disclosed |
| CN-110891941-A | Substituted 5- (hetero) arylpyrazolamides and their salts and their use as herbicidally active substances | 拜耳作物科学股份公司 | 2020-03-17 | — | — | CN | disclosed |
| EP-1731509-B1 | PROCESS FOR PRODUCING NITROGENOUS 5-MEMBERED CYCLIC COMPOUND | JAPAN SCIENCE & TECH AGENCY (JP) | 2011-10-19 | — | — | EP | disclosed |
| US-7705161-B2 | Process for producing nitrogenous 5-membered cyclic compound | JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) | 2010-04-27 | — | — | US | disclosed |
| US-20070191614-A1 | Process for producing nitrogenous 5-membered cyclic compound | JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) | 2007-08-16 | — | — | US | disclosed |
| EP-1731509-A1 | PROCESS FOR PRODUCING NITROGENOUS 5-MEMBERED CYCLIC COMPOUND | Japan Science and Technology Agency (JP) | 2006-12-13 | — | — | EP | disclosed |
| US-5108880-A | Developing agent, sulfite preservative and amino alcohol | SUN CHEMICAL CORPORATION (US) | 1992-04-28 | — | — | US | disclosed |
| EP-0011693-A1 | N-trifluoromethane-sulfonylaminophenyl-substituted N-heterocycles, their preparation, compositions containing them and their use in regulating plant growth | CIBA-GEIGY AG (CH) | 1980-06-11 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070191614-A1 | Process for producing nitrogenous 5-membered cyclic compound | HRH4, HRH2, HRH1 | ALOX5 1004/4885GNAO1 628/4885GNAI3 699/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.